
In the absence of an efficient diagnostic modality for Tuberculosis, the search for a tool that can overcome the dilemmas of the available diagnostic tests continues. In…
Read more »In the absence of an efficient diagnostic modality for Tuberculosis, the search for a tool that can overcome the dilemmas of the available diagnostic tests continues. In…
Read more »India accounts for approximately one-quarter of the world’s 9 million incident tuberculosis cases every year. The TB epidemic in India is complicated by the fragmented healthcare delivery system that…
Read more »Tuberculosis is one of the world’s deadliest communicable diseases. Of the estimated 9.6 million new TB cases in 2014, India alone accounted for 23% of total cases. While most cases of TB are…
Read more »Interferon-gamma Release Assays (IGRAs), including QuantiFERON-TB Gold In Tube (Cellestis, Carnegie, Australia) and T-SPOT.TB (Oxford Immunotec, Oxfordshire, UK), are immunological tests that are widely used to detect…
Read more »India has the world’s largest burden of tuberculosis (TB) and accounts for one-fifth of the global TB incidence. While, globally the exact burden of childhood TB is not well documented, it is estimated that…
Read more »In India, despite impressive progress in the scale-up of DOTS (Directly Observed Treatment Short course) coverage by the public sector, tuberculosis (TB) remains a pressing public health problem, owing partly to a…
Read more »
Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India
Every year approximately 1.5 million people die of Tuberculosis globally, and most of these occur in the developing countries. India is one of the 22 TB high burden countries in the world; approximately 2.2 million cases in 2014 out of…
Read more »